Beyond Triptans: A Review of New Migraine Medications in Clinical Trials

dc.contributor.authorNakagawa, Christopher
dc.contributor.authorHino Jr., Garret
dc.contributor.authorTokumaru, Sheri
dc.contributor.authorYoung, Nicole
dc.contributor.instructorTokumaru, Sheri
dc.contributor.instructorYoung, Nicole
dc.date.accessioned2018-04-06T23:28:24Z
dc.date.available2018-04-06T23:28:24Z
dc.date.issued2018-04-06
dc.descriptionPoster
dc.description.abstractMigraines are a very common and debilitating headache disorder characterized by moderate to severe throbbing headache pain, which can be associated with nausea, vomiting, sensitivity to light and sensitivity to sound.This study is a literature review of recent and ongoing clinical trials for new classes of pharmacologic treatments for acute migraine.
dc.format.extent1
dc.identifier.urihttp://hdl.handle.net/10790/3449
dc.language.isoen-US
dc.rightsopen access
dc.subjectMigraine
dc.subjectCGRP Blocking Drugs
dc.subjectCGRP Targeted Monoclonal Antibodies
dc.subjectALLOD-2
dc.subjectSerotonin 5HT1F Receptor Blockers
dc.titleBeyond Triptans: A Review of New Migraine Medications in Clinical Trials
dc.typePresentation
dc.type.dcmiText

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Migraine Poster.pdf
Size:
28.17 MB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.62 KB
Format:
Item-specific license agreed upon to submission
Description: